Antiseizure Meds With Known or Uncertain Risks Continue to Be Prescribed in Pregnancy

Follow Drugslib on

By Elana Gotkine HealthDay Reporter

Medically reviewed by Carmen Pope, BPharm. Last updated on July 28, 2025.

via HealthDay

MONDAY, July 28, 2025 -- Despite a shift from valproate to safer antiseizure medications (ASMs) in pregnancy, many medications with known or uncertain risks are still being prescribed, according to a study published online July 23 in Neurology.

Pouneh Shahriari, from the French National Agency for the Safety of Medicines and Health Products in Saint-Denis, France, and colleagues examined trends in prenatal exposure to ASMs in a nationwide, population-based study. The study included 55,801 ASM-exposed pregnancies that ended between 2013 and 2021.

The researchers observed a 30 percent increase in pregnancies exposed to the safest ASMs (lamotrigine and levetiracetam). Prenatal exposure to ASMs with acknowledged risk, including valproic acid and valpromide, decreased due to a reduction in the number of exposed pregnancies (−84 and −89 percent, respectively), an increasing termination rate of exposed pregnancies (+23 and +28 percent, respectively), and among those pregnancies that ended in childbirth, reduced numbers with multiple dispensations (−86 and −93 percent, respectively) or sustained exposure (−91 and −96 percent, respectively) throughout pregnancy. There was almost no decrease in prenatal exposure to carbamazepine and topiramate, which have acknowledged risk, with almost 600 newborns still exposed to each of these in 2019 to 2021. ASMs with uncertain risk, including pregabalin and gabapentin, became widely used during pregnancy.

"These disparities could be due to various factors, including more frequent unplanned pregnancies and suboptimal care before conception or during pregnancy for people who are socioeconomically disadvantaged," coauthor Rosemary Dray-Spira, M.D., Ph.D., also from the French National Agency for the Safety of Medicines and Health Products, said in a statement. "Use of the drugs with the greatest risks has decreased, and use of the safest drugs has increased, but we are concerned to still see use during pregnancy of some drugs with known risks and new drugs with uncertain risk."

Abstract/Full Text

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

Source: HealthDay

Posted : 2025-07-29 06:00

Read more

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Popular Keywords